Comparing Types of HRT for Menopause - Pills, Patches, Gels

Comparing Types of HRT for Menopause: Pills, Patches, Gels, and More

  • Medically reviewed by: Katelyn Schwartz, NP, Family Nurse Practitioner with Advanced Training in TRT, BHRT, and Menopause Care
  • Last reviewed: November 2026

Navigating menopause can feel like a journey with no clear map. Hot flashes, broken sleep, and mood swings lead many women to look at hormone replacement therapy (HRT). Then a second question arrives: tablet, patch, gel, or something else?

This guide compares the main types of HRT for menopause side by side. For each one, you will see how it is used, how often, who it may suit, and how blood clot risk changes with the route. It also covers vaginal estrogen, bioidentical hormones, and which forms are available and covered in Canada.

Understanding HRT for Menopause

HRT, also called menopause hormone therapy (MHT), replaces some of the estrogen your ovaries stop making. Women who still have a uterus also take a progestogen. That can be natural progesterone or a synthetic progestin, and its job is to protect the lining of the uterus.

HRT types differ in three ways, and it helps to keep them apart:

  • By hormone: estrogen-only HRT, usually after a hysterectomy, or combined HRT with estrogen plus a progestogen.
  • By route: tablets, skin patches, gels, sprays, or vaginal products.
  • By reach: systemic HRT acts on the whole body, while low-dose vaginal estrogen works mainly where it is placed.

Most decisions come down to the route. The route changes how your body processes the hormone, and that in turn shapes side effects and clot risk.

How HRT Helps with Menopause Symptoms

Estrogen does far more than run the reproductive cycle. It also helps regulate body temperature, supports bone strength and keeps vaginal and urinary tissue healthy. As levels fall, symptoms can appear in several places at once, and they differ in severity and duration from one woman to the next.

HRT may ease many of these symptoms, including:

  • Hot flashes and night sweats: sudden waves of heat that can interrupt work, conversation and sleep.
  • Mood swings and anxiety: shifting hormone levels can leave some women irritable, low or on edge.
  • Vaginal dryness: thinner, drier tissue can make sex uncomfortable and raise the chance of urinary symptoms.
  • Bone loss: estrogen helps maintain bone density, and HRT has been shown to prevent bone loss and fracture.

The hormone is the same in most forms. What changes is the route, and the route decides how steady your levels are, which side effects show up, and how your liver responds.

Types of HRT side by side: a skin patch, a tube of gel, tablets and capsules

Types of HRT for Menopause

These are the main HRT types, starting with the one most readers search for:

  • Skin patches
  • Gels
  • Sprays
  • Tablets and capsules
  • Vaginal estrogen
  • Combined and estrogen-only HRT

HRT Patches: Steady Estrogen Through the Skin

HRT patches are thin adhesive patches that release estradiol through the skin and into the bloodstream. Most are changed twice a week, and some once a week. Because the estrogen does not pass through the liver first, large studies have not linked patches to the rise in clot risk seen with tablets.

Combined patches also exist. They carry estradiol plus a progestin, so a woman with a uterus can get both hormones from one patch.

How it is used: Canadian product information names the buttock as the preferred site, with the side, hip, lower back, or lower abdomen as other options. Rotate sites each time, and never place a patch on the breast.

If you miss a change: put on a new patch as soon as you remember, then go back to your usual change days. If a patch falls off in a hot bath or shower, shake off the water, dry the skin, and press it onto a new spot. And if it will not stick, use a fresh patch.

Who it may suit: women who want steady hormone levels without a daily step. Patches may also suit women with a higher clot risk, such as smokers, women over 60, and women with migraine without aura.

Drawbacks: the adhesive can irritate the skin, edges may lift with sweat or water, and some women dislike a patch that shows under clothing.

HRT Gels: A Daily Dose You Rub In

Estrogen gel contains estradiol in a clear gel. A pump measures each dose, and you spread it once a day over a wide area of clean, dry skin, usually the arms, abdomen, or inner thighs. Like a patch, the gel is absorbed through the skin rather than through the gut.

How it is used: let the gel dry for about two minutes before you dress. Keep it off the breasts, the face, and any broken or irritated skin.

If you miss a dose: apply it when you remember. If your next dose is due soon, skip the missed one, and never double up.

A safety point for families: gel can rub off onto other people. Keep children away from the treated skin, and wash a child’s skin with soap and water if contact happens.

Who it may suit: women who react to adhesives or whose provider wants room to adjust the dose in small steps.

HRT Sprays: Not Currently a Canadian Option

An estradiol spray delivers a measured mist of estrogen onto the skin. The Menopause Society lists sprays alongside patches and gels as a transdermal route. In Canada, however, no estradiol spray appears in the Canadian Pharmacists Association’s March 2026 list of estrogen products marketed here. For Canadian women, the transdermal choice today is a patch or a gel.

HRT Patches or Gel: Which Is Better?

Neither is better for everyone. Patches and gels deliver the same hormone, estradiol, through the skin, and neither has shown the clot signal seen with tablets. In practice, the choice comes down to routine. A patch is changed once or twice a week, while a gel goes on every day but is often easier to fine-tune.

Feature Patch Gel
How often Once or twice a week Every day
Daily effort None between changes Pump, spread, wait about 2 minutes
Skin issues Adhesive irritation is possible Can transfer to others by touch
Dose changes Set patch strengths Often easier to adjust in small steps
Water and sweat Edges may lift Must dry before clothing or contact
Clot risk vs. tablets No increase seen in large studies No increase seen in large studies

Research has not settled whether one is safer than the other. Large studies, including the UK study described below, usually group patches and gels together as “transdermal” HRT. The clot evidence therefore applies to both. If one form irritates your skin or does not fit your day, moving to the other keeps the same hormone and the same route.

HRT Tablets: Names, Types, and How They Are Taken

Among HRT medications, tablets are the oldest and most familiar type. You swallow one each day, which suits women who already have a daily pill routine. The names of HRT tablets usually describe the hormone inside, and they fall into three groups:

  • Estrogen tablets: estradiol, which is identical to the estrogen the ovaries make, or conjugated estrogens, a mixture of several estrogens.
  • Progestogen tablets and capsules: micronized progesterone, which is identical to natural progesterone, or a progestin such as medroxyprogesterone acetate.
  • Combined tablets: estradiol paired with a progestin, such as norethindrone acetate or drospirenone, or with progesterone, in one daily tablet or capsule.
Woman sitting on her bed holding a tablet and a glass of water

Why Tablets Behave Differently

A swallowed estrogen is absorbed from the gut and travels to the liver before it reaches the rest of the body. That first pass is thought to prompt the liver to make more of the proteins involved in blood clotting. As a result, tablets carry a clot risk that patches and gels do not appear to share.

If you miss a dose: take it when you remember. If the next dose is close, skip the missed one and carry on, and never take two at once.

Who tablets may suit: women under 60 or within 10 years of their last period who have no clot risk factors and like the simplicity of a pill. In the UK study below, estradiol tablets carried a lower clot risk than conjugated estrogens.

Who may want another route: the Canadian Menopause Society says transdermal estrogen may be preferable for smokers and shift workers. The same applies to women with high triglycerides, high blood pressure, migraines, diabetes, metabolic syndrome or gallbladder disease, and to those at higher risk of clots or heart disease. A past clot in a vein is listed as a reason not to use systemic estrogen at all, so it needs a careful review first. Micronized progesterone capsules are usually taken at bedtime, since they can cause drowsiness.

Vaginal Estrogen: Local HRT for Dryness and Urinary Symptoms

Vaginal estrogen is its own type of HRT, built for a different job. It treats the genitourinary syndrome of menopause (GSM): dryness, burning, pain with sex, and urinary urgency or repeat infections caused by thinning tissue. The North American Menopause Society estimates that GSM affects roughly 27% to 84% of postmenopausal women. Unlike hot flashes, it often worsens with age and time since menopause.

Several local forms are available in Canada:

  • Vaginal tablets or inserts: one a day for two weeks, then about twice a week.
  • Vaginal ring: a soft ring you place yourself and replace every three months.
  • Vaginal cream: used daily at first, then two or three times a week.
  • Vaginal DHEA insert: a nightly insert containing DHEA, a hormone the vaginal tissue converts locally.

Very little of the hormone reaches the bloodstream. For that reason, the Canadian Menopause Society says the standard contraindications for systemic HRT do not apply. It also says a progestogen is not needed to protect the uterus with low-dose vaginal estrogen. Some women use vaginal estrogen on its own, while others add it to a patch, gel, or tablet when dryness persists.

If you miss a dose: use it when you remember unless your next dose is close, and never use two to catch up. For women with a history of breast cancer, the decision is best made with the oncology team.

Combined vs. Estrogen-Only HRT

On its own, estrogen gradually thickens the lining of the uterus, which raises the risk of endometrial cancer. Women who still have a uterus therefore add a progestogen. Women who have had a hysterectomy can usually take estrogen alone.

The progestogen can come in several forms:

  • a tablet or capsule taken daily, or for part of each month;
  • a combined patch with both hormones;
  • a combined daily tablet;
  • a hormonal IUD that releases levonorgestrel into the uterus.

The Canadian Menopause Society says micronized progesterone is preferable for higher-risk women who need endometrial protection. It also notes that only one hormonal IUD marketed in Canada has evidence for protecting the endometrium, so the specific device matters.

The type of progestogen also shapes risk. The North American Menopause Society states that the risks of hormone therapy differ by type, dose, duration, route, timing of initiation, and whether a progestogen is used. That is one reason two women on “HRT” can face quite different trade-offs.

Bioidentical Hormones: What the Word Really Means

Bioidentical means a hormone has the same chemical structure as the one your body makes. It describes the molecule, not where it was made or how “natural” it feels.

Many standard HRT products in Canada already fit that definition. Estradiol, the hormone in most patches, gels, estrogen tablets and vaginal products, is bioidentical. So is micronized progesterone. These products are approved by Health Canada, made to a consistent strength, and supplied with full product information.

Compounded bioidentical hormones are different. A pharmacy mixes them to order, often as creams or capsules. SOGC guidance says their safety and efficacy have not been assessed with the same rigour as Health Canada approved hormone therapy. The Menopause Society adds that custom-compounded hormones are not safer or more effective than approved bioidentical hormones, and may not contain the amount prescribed.

In short, compounded products are less studied and less regulated, rather than proven harmful. Our guide to compounded vs. approved BHRT covers the differences in more depth.

HRT Types Compared at a Glance

This table brings the main types of HRT together in one place. Your own plan will depend on your health history and should be set with a licensed provider.

Type How it is taken How often May suit Clot risk If a dose is missed
Estrogen tablet Swallowed Once a day Under 60, low clot risk, likes a pill Raised: 58% higher odds than no HRT Take when remembered; skip if next dose is close
Estrogen patch Stuck on the buttock, hip or lower abdomen Once or twice a week Smokers, over 60, migraine without aura, no daily step No increase seen in large studies Apply a new patch, then keep usual change days
Estrogen gel Rubbed onto arms, abdomen or thighs Once a day Dislikes adhesives, needs small dose changes No increase seen in large studies Apply when remembered; never double up
Estrogen spray Sprayed onto the skin Varies by product Not marketed in Canada as of March 2026 Transdermal route Not applicable in Canada
Combined tablet or patch Swallowed or stuck on Daily tablet, or patch once or twice a week Has a uterus, wants one product Follows the route: tablet raised, patch not As for the tablet or patch
Vaginal tablet, insert or cream Placed in the vagina Daily for 2 weeks, then 2 to 3 times a week Dryness, painful sex, urinary symptoms Very little reaches the blood Use when remembered; never use two
Vaginal ring Placed in the vagina Replaced every 3 months Local symptoms, less frequent handling Very little reaches the blood Not a daily product; follow the leaflet

The UK Clot Study: Why the Route Matters

The strongest single piece of evidence on HRT types comes from a 2019 UK study published in The BMJ. Researchers compared 80,396 women aged 40 to 79 who had a blood clot in a vein, known as venous thromboembolism (VTE), with 391,494 women who had not. The data came from general practice records between 1998 and 2017.

Key finding: women taking oral HRT had 58% higher odds of a vein clot than women not using HRT. Women using estrogen through the skin, by patch or gel, showed no increase.

  • Oral HRT: an odds ratio of 1.58 compared with no HRT.
  • Transdermal HRT: an odds ratio of 0.93, a result consistent with no added risk.
  • Among tablets: estradiol carried a lower risk than conjugated estrogens.

Two points keep this finding in proportion. First, the 58% compares tablet users with women not taking HRT, not with patch users. The practical message is the same, though: the skin route did not carry the extra risk. Second, it is a relative figure. For a healthy woman in her early 50s, the starting risk of a clot is low, so the added risk from tablets is small in absolute terms. It grows with age, weight, smoking and a past clot.

Smoking deserves its own mention, because it stacks onto the oral route. Canadian product information for estrogen notes that the risk of VTE increases with age and smoking. Our guide to HRT for smokers explains which forms are usually preferred. Age is the other multiplier, which our guide to choosing a patch or pill after 60 explains.

Healthcare provider in a white coat reviewing notes with an older woman

How to Choose the Right Type of HRT

Choosing a type of HRT is a shared decision between you and a licensed provider. It usually starts with four questions:

  • Do you have a uterus? If so, you will need a progestogen with systemic estrogen.
  • What is your clot risk? Being over 60, smoking, a higher body weight, migraine without aura or a family history of clots all point toward a patch or gel. A personal history of clots needs a fuller review first.
  • Are your symptoms whole-body or local? Hot flashes and night sweats call for systemic HRT, while dryness alone may only need vaginal estrogen.
  • What fits your routine? A daily tablet or gel, or a patch changed once or twice a week.

If you would like help weighing these, our menopause hormone therapy program reviews your history, symptoms and preferences before suggesting a form.

Switching Between HRT Types

Your first choice is not permanent. Patients often switch when a patch irritates the skin, when progesterone makes them drowsy, or when hot flashes return. The Canadian Menopause Society lists a lower dose or a different route among the options for troublesome side effects such as bleeding. The Canadian Pharmacists Association also advises monitoring and dose adjustment after any switch between products.

If symptoms are still there after a fair trial, review the signs HRT is not working before changing anything yourself. One rule matters most: a woman with a uterus who moves from combined HRT to an estrogen-only product still needs a progestogen.

Which HRT Types Are Available and Covered in Canada?

Canada has a broad range of HRT types. These include estradiol patches (estrogen-only and combined), estradiol gel, estrogen tablets, combined tablets and capsules, and micronized progesterone. Local options include vaginal tablets, inserts, rings and creams. As noted above, an estradiol spray is not on the current Canadian list.

Coverage depends on where you live:

  • British Columbia: since March 1, 2026, BC PharmaCare’s Plan NP has covered 100% of the cost of menopause hormone therapy for residents enrolled in MSP. That includes oral estradiol, oral conjugated estrogen, oral micronized progesterone, oral medroxyprogesterone, vaginal estrogen, and estrogen or estrogen/progesterone gels and patches. Coverage is processed at the pharmacy counter.
  • Manitoba: since April 15, 2025, the Manitoba Enhanced Pharmacare Program has covered most HRT products at no cost, up to the lowest-cost interchangeable product. Some products need prior approval.
  • Other provinces and territories: coverage runs through public drug plans, which usually depend on age or income, or through private workplace insurance. Your pharmacist can tell you which forms your plan lists.

Supply has also been uneven at times. In March 2026, the Canadian Pharmacists Association published guidance on a menopause hormone therapy shortage. If your usual form is unavailable, a provider can often move you to an equivalent product or route.

Benefits and Risks of HRT

Benefits of HRT

The North American Menopause Society calls hormone therapy the most effective treatment for hot flashes and for genitourinary symptoms. Potential benefits include:

  • Symptom relief: fewer and milder hot flashes and night sweats, and some women report steadier moods.
  • Bone health: HRT has been shown to prevent bone loss and fracture.
  • Better sleep: with fewer night sweats, sleep may become more restful.
  • Vaginal and urinary comfort: estrogen may restore moisture and thickness to thinning tissue.

Risks of HRT

The balance shifts with age and timing. For women under 60, or within 10 years of menopause, who have no contraindications, the North American Menopause Society describes the benefit-risk ratio as favourable. Starting more than 10 years after menopause, or after 60, it appears less favourable.

  • Blood clots: higher with tablets than with patches or gels.
  • Heart disease and stroke: absolute risks are greater when therapy starts after 60 or more than 10 years past menopause.
  • Breast cancer: risk varies with the type of therapy, whether a progestogen is used, and how long therapy continues.

Common Side Effects of HRT

Many women find HRT easy to live with, but some notice side effects early in treatment. These can include:

  • headaches or nausea;
  • breast tenderness;
  • bloating and fluid retention;
  • changes in mood;
  • spotting or irregular bleeding with combined therapy.

Some side effects belong to one form, such as skin redness under a patch or drowsiness from micronized progesterone. Most settle as the body adjusts. Report any that persist, and any unexpected bleeding, to your provider.

Who Should Steer Clear of HRT?

Canadian product information lists situations in which systemic estrogen should not be used:

  • liver disease, until liver tests return to normal;
  • known or suspected estrogen-dependent cancer, such as endometrial cancer;
  • endometrial hyperplasia (thickening of the uterine lining);
  • known, suspected or past breast cancer;
  • unexplained vaginal bleeding;
  • known or suspected pregnancy, or breastfeeding;
  • current or past arterial clotting disease, such as stroke, heart attack or coronary heart disease;
  • classical migraine (migraine with aura);
  • a current or past clot in a vein, such as deep vein thrombosis or pulmonary embolism, or active thrombophlebitis;
  • known inherited or acquired clotting disorders (thrombophilia);
  • porphyria;
  • partial or complete vision loss caused by disease of the eye’s blood vessels;
  • allergy to estradiol or any other ingredient in the product.

Low-dose vaginal estrogen is the main exception, because so little is absorbed. For women who cannot or prefer not to use hormones, several non-hormonal options exist, as the FAQ below explains.

Talking It Through With a Licensed Provider

The right type of HRT is the one that matches your body, your risks and your routine, and finding it takes a real conversation. A licensed Nurse Practitioner can review your history, blood pressure, clot risk and symptoms. From there, you can agree on a starting form and a plan to review it after a few months.

FAQ

Q: What are the types of HRT?

The main types of HRT are estrogen-only and combined (estrogen plus a progestogen). They come as tablets, skin patches, gels, sprays and vaginal products. Systemic forms treat hot flashes and other whole-body symptoms, while low-dose vaginal estrogen treats dryness and urinary symptoms locally. Sprays are not currently marketed in Canada.

Q: Which type of HRT is safest?

No single type is safest for everyone, but the route matters for blood clots. In a large UK study, HRT tablets were linked to 58% higher odds of a vein clot than no HRT, while patches and gels showed no increase. Low-dose vaginal estrogen has the least exposure. Your age, health history and whether you have a uterus decide what is safest for you.

Q: Are HRT patches or tablets better?

Patches may suit women with a higher clot risk, such as smokers, women over 60 or women with migraine without aura, and anyone who prefers not to take a daily pill. Tablets may suit younger women with low clot risk who like a simple routine. Both can relieve hot flashes. The main difference is how the liver handles the estrogen.

Q: Can I switch between HRT types?

Yes. Many women move from tablets to a patch or gel, or between a patch and a gel, because of side effects, clot risk or convenience. Make the switch with your provider rather than on your own, since doses are not interchangeable one-to-one. Anyone with a uterus still needs a progestogen after the change.

Q: How long can you stay on HRT?

There is no fixed time limit. The Canadian Menopause Society sets no mandatory stopping point and says stopping at 65 is not necessary. Instead, it recommends a yearly review of benefits and risks at the lowest effective dose. How long you continue depends on your symptoms, your health and your own preferences.

Q: Are there non-hormonal alternatives to HRT?

Yes. The North American Menopause Society’s 2023 statement supports cognitive behavioural therapy and clinical hypnosis for hot flashes. It also supports several prescription options, including certain antidepressants, an anti-seizure medicine, an overactive-bladder medicine and a newer brain-targeted tablet. It does not recommend herbal remedies, soy, yoga or exercise as treatments for hot flashes.

Q: Does HRT cause weight gain?

Research does not support that link. A Cochrane review of 28 randomized trials found no evidence that HRT changes body weight beyond the gain typically seen at menopause. Weight change in midlife is tied more closely to age and lifestyle, although some women notice bloating in the first weeks of treatment.

Conclusion

The types of HRT for menopause share one goal, replacing estrogen, but they reach it by different paths. Patches and gels send estrogen through the skin and have not shown the clot risk linked to tablets. Tablets suit some women well. Vaginal estrogen treats local symptoms with very little absorption, and approved bioidentical options are already part of standard care in Canada.

If you would like help finding the form that fits your health and your routine, our licensed Nurse Practitioners can walk you through the options. Book a women’s consultation to get started. Individual results depend on your health history, symptoms and how your body responds.

This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

References

  1. Use of Hormone Replacement Therapy and Risk of Venous Thromboembolism: Nested Case-Control Studies Using the QResearch and CPRD Databases, Vinogradova et al., BMJ 2019 — PubMed Central
  2. Menopause Management Pocket Guide, 2nd Edition 2023 — Canadian Menopause Society
  3. Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle — SOGC, Journal of Obstetrics and Gynaecology Canada
  4. The 2022 Hormone Therapy Position Statement of The North American Menopause Society — Menopause (PubMed)
  5. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society — Menopause (PubMed)
  6. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society — Menopause (PubMed)
  7. Menopause Topics: Hormone Therapy — The Menopause Society
  8. Menopausal Hormone Therapy Shortage, March 2026 — Canadian Pharmacists Association
  9. BC PharmaCare Plan NP (National Pharmacare Plan) — Government of British Columbia
  10. Manitoba Enhanced Pharmacare Program — Government of Manitoba
  11. Product Monograph: Estradiol-17β Transdermal Patch, 2024 — Health Canada Drug Product Database
  12. Product Monograph: Estradiol Transdermal Gel, 2025 — Health Canada Drug Product Database
  13. Product Monograph: Estradiol-17β Oral Tablets, 2022 — Health Canada Drug Product Database
  14. Product Monograph: Estradiol Vaginal Inserts, 2023 — Health Canada Drug Product Database
  15. Hormone Replacement Therapy Has No Effect on Body Weight and Cannot Prevent Weight Gain at Menopause — Cochrane